Medexus Pharmaceuticals Inc. (TSX:MDP)

Medexus Pharmaceuticals Revenue

Medexus Pharmaceuticals had revenue of $28.59M USD in the quarter ending June 30, 2026, with 16.13% growth. This brings the company's total for the last twelve months to $103.30M, down -2.24% year-over-year. In the fiscal year ending March 31, 2026, Medexus Pharmaceuticals had annual revenue of $99.33M, down -8.31%. That makes Medexus Pharmaceuticals the 22,315th largest company in the world by revenue and 421st in Canada.

• Revenue (ttm): $103.30M
• Revenue Growth: -2.24%
• P/S Ratio: 1.08
• Revenue / Employee: $1.15M
• Employees: 90
• Market Cap: 154.93M CAD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Geography

Chart

• United States 74.74M 75.2%
• Canada 24.59M 24.8%

Fiscal year ended Mar 31, 2026 See the full Medexus Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	99.33M	-9.00M	-8.31%
Mar 31, 2025	108.33M	-4.72M	-4.18%
Mar 31, 2024	113.05M	4.96M	4.59%
Mar 31, 2023	108.10M	31.40M	40.93%
Mar 31, 2022	76.70M	-2.96M	-3.71%

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error